Some decisions are hard. Others, however, are so easy that they require much less thought.

Three Motley Fool contributors believe they've found stocks to buy that definitely fall into the latter category. Here's why they think (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer stocks to buy right now.

Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie isn't currently popular with investors. The company's shares are down by 14% year to date. It's no wonder: AbbVie's financial results are suffering due to its losing U.S. patent exclusivity for Humira, its best-selling medicine. Patent cliffs for therapies that generate billions in sales can be hard to navigate for drugmakers, and the market doesn't seem too confident that AbbVie will do a good job of it. That's a mistake.

Continue reading

Source Fool.com